DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma

NCT00862303 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

BIOLOGICAL: DC-CIK
DRUG: IL-2/IFN-α

Sponsor

Fuzhou General Hospital